MASOLA, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.103
AS - Asia 360
EU - Europa 354
OC - Oceania 3
AF - Africa 2
SA - Sud America 2
Totale 3.824
Nazione #
US - Stati Uniti d'America 3.100
CN - Cina 176
SG - Singapore 134
IT - Italia 101
FI - Finlandia 59
SE - Svezia 49
DE - Germania 39
GB - Regno Unito 31
FR - Francia 30
UA - Ucraina 20
HK - Hong Kong 16
VN - Vietnam 14
IN - India 12
RU - Federazione Russa 10
IE - Irlanda 7
AT - Austria 3
AU - Australia 3
CA - Canada 3
JP - Giappone 3
MY - Malesia 3
PL - Polonia 3
BR - Brasile 2
PH - Filippine 2
ZA - Sudafrica 2
BG - Bulgaria 1
RO - Romania 1
Totale 3.824
Città #
Fairfield 537
Woodbridge 289
Houston 278
Ann Arbor 231
Ashburn 222
Seattle 209
Cambridge 199
Chandler 174
Wilmington 173
Singapore 109
Jacksonville 104
Santa Clara 88
Boardman 74
Princeton 56
Beijing 52
Padova 48
San Diego 42
Medford 38
Helsinki 33
Des Moines 28
Nanjing 25
Hong Kong 16
Dong Ket 13
Guangzhou 11
Hebei 8
Shenyang 7
Cagliari 6
Dublin 6
Falls Church 6
Jinan 6
London 6
Nanchang 6
Norwalk 6
Redmond 6
Zhengzhou 5
Bologna 4
Jiaxing 4
Kilburn 4
New York 4
Ogden 4
Piacenza 4
Rome 4
Haikou 3
Las Vegas 3
Redwood City 3
Shanghai 3
Sungai Petani 3
Sydney 3
Tianjin 3
Borås 2
Brendola 2
Como 2
Council Bluffs 2
Frankfurt am Main 2
Hangzhou 2
Heidelberg 2
Hounslow 2
Kollam 2
Latham 2
Milan 2
Novosibirsk 2
Ostellato 2
Petilia Policastro 2
Phoenix 2
Quanzhou 2
Rio de Janeiro 2
Roxbury 2
Stockholm 2
Vicenza 2
Vienna 2
Washington 2
Auburn Hills 1
Belluno 1
Carlow 1
Cesiomaggiore 1
Changsha 1
Chicago 1
Civitanova Marche 1
Düsseldorf 1
Easton 1
Hakusan 1
Higashifukai 1
Indiana 1
Jieyang 1
Johannesburg 1
Kharkiv 1
Leawood 1
Los Angeles 1
Marcallo con Casone 1
Minneapolis 1
Montreal 1
Munich 1
Nashville 1
Ningbo 1
Palermo 1
Pisa 1
Prescot 1
Prineville 1
Ryazan 1
Skawina 1
Totale 3.239
Nome #
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 143
Heparanase and macrophage interplay in the onset of liver fibrosis 142
Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells. 141
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells 130
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 124
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 121
L-citrulline Prevents Alveolar and Vascular Derangement in a Rat Model of Moderate Hyperoxia-induced Lung Injury. 112
Recent data concerning heparanase: Focus on fibrosis, inflammation and cancer 111
L: -citrulline Prevents Alveolar and Vascular Derangement in a Rat Model of Moderate Hyperoxia-induced Lung Injury. 109
Antidepressant hyperforin up-regulates VEGF in CNS tumour cells. 107
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition. 107
Impact of heparanase on renal fibrosis 101
Collagen Fiber Array of Peritumoral Stroma Influences Epithelial-to-Mesenchymal Transition and Invasive Potential of Mammary Cancer Cells 100
Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells. 99
Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells. 98
HEPARANASE ACTIVITY IN ALVEOLAR AND EMBRYONAL RHABDOMYOSARCOMA: IMPLICATIONS FOR TUMOR INVASION. 96
Expression of LGI1 impairs proliferation and survival of HeLa cells 93
Heparanase: Another renal player controlled by Vitamin D 93
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition 93
Molecular size-dependent specificity of hyaluronan on functional properties, morphology and matrix composition of mammary cancer cells 92
Role of heparanase in tumor progression: Molecular aspects and therapeutic options 92
Impact of Heparanse on Organ Fibrosis 92
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury 91
Involvement of heparanase in the pathogenesis of acute kidney injury: Nephroprotective effect of PG545 90
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells 87
Heparanase: A potential new factor involved in the renal Epithelial Mesenchymal Transition (EMT) induced by Ischemia/Reperfusion (I/R) injury 87
The story of SPATA2 (Spermatogenesis-associated Protein 2): from Sertoli cells to pancreatic beta-cells. 85
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 75
LGI1 Affects survival of neuroblastoma cells by inhibiting signalling through phosphoinositide 3-Kinase 74
Heparanase e rene. Regolazione e ruolo dell'heparanase a livello tubulare e nella nefropatia diabetica. 73
Long filopodia and tunneling nanotubes define new phenotypes of breast cancer cells in 3D cultures 67
Heparanase as a target in cancer therapy. 65
Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events 63
A guide to the composition and functions of the extracellular matrix 61
HYPERFORIN EFFECTS ON VEGF EXPRESSION LEVEL IN BRAIN TUMOUR CELL LINES 52
Fluoxetine may worsen hyperoxia-induced lung damage in neonatal rats 43
Heparanase is a player in renal fibrosis by regulating TGF-β expression and activity. 43
Endothelial glycocalyx as a regulator of fibrotic processes 43
Risposta immunologica umorale anti-ALK ed attività  eparanasica nel linfoma anaplastico a grandi cellule pediatrico: due muovi marker biologici? 40
Basement Membrane, Collagen, and Fibronectin: Physical Interactions with Cancer Cells 37
Biological effects of xylocore, a glucose sparing pd solution, on mesothelial cells: Focus on mesothelial-mesenchymal transition, inflammation and angiogenesis 36
Renal effect of severe hypoxia evaluated By NGAL measurements: An in vivo and in vitro study 34
Heparanase as active player in endothelial glycocalyx remodeling 34
L-citrulline is protective in hyperoxic lung damage and improbe matrix remodelling and alveolarization. In: LXV Congresso della Società Italiana di Anatomia e Istologia, Padova, 2011. 29
STUDO DELL’HEPARANASE IN PATOLOGIE RENALI E DI UNA POSSIBILE STRATEGIA PER LA SUA INIBIZIONE 27
Extracellular Matrix-Mediated Breast Cancer Cells Morphological Alterations, Invasiveness, and Microvesicles/Exosomes Release 27
Heparanase: A Paramount Enzyme for Cancer Initiation, Progression, and Metastasis 20
The role of SPATA2 in TNF signaling, cancer, and spermatogenesis 18
How to improve the biocompatibility of peritoneal dialysis solutions (Without jeopardizing the patient’s health) 17
Substrate Type and Concentration Differently Affect Colon Cancer Cells Ultrastructural Morphology, EMT Markers, and Matrix Degrading Enzymes 15
Studying the Effects of Glycosaminoglycans in Cell Morphological Aspect with Scanning Electron Microscopy 15
Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis 14
Colorectal Cancer Cell Invasion and Functional Properties Depend on Peri-Tumoral Extracellular Matrix 8
Heparanase regulates EMT and cancer stem cell properties in prostate tumors 6
Rationale and Design of PURE: A Randomized Controlled Trial to Evaluate Peritoneal Ultrafiltration with PolyCore™ in Refractory Congestive Heart Failure 2
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander? 1
Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge 1
Totale 3.876
Categoria #
all - tutte 16.039
article - articoli 14.736
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 602
Totale 31.377


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020413 0 0 0 0 0 0 76 83 90 69 64 31
2020/2021683 26 35 78 41 22 41 26 55 89 130 65 75
2021/2022681 51 52 96 49 42 27 51 68 50 25 52 118
2022/2023423 84 31 3 42 69 51 1 42 61 6 21 12
2023/2024254 27 29 33 22 11 15 17 24 12 3 30 31
2024/2025401 3 79 47 36 185 47 4 0 0 0 0 0
Totale 3.876